Logo image of ICL

ICL GROUP LTD (ICL) Stock Fundamental Analysis

NYSE:ICL - New York Stock Exchange, Inc. - IL0002810146 - Common Stock - Currency: USD

6.85  +0.01 (+0.15%)

After market: 6.82 -0.03 (-0.44%)

Fundamental Rating

5

Overall ICL gets a fundamental rating of 5 out of 10. We evaluated ICL against 85 industry peers in the Chemicals industry. While ICL has a great profitability rating, there are some minor concerns on its financial health. ICL has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ICL had positive earnings in the past year.
ICL had a positive operating cash flow in the past year.
ICL had positive earnings in each of the past 5 years.
ICL had a positive operating cash flow in each of the past 5 years.
ICL Yearly Net Income VS EBIT VS OCF VS FCFICL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

The Return On Assets of ICL (3.60%) is better than 68.24% of its industry peers.
With a decent Return On Equity value of 7.11%, ICL is doing good in the industry, outperforming 61.18% of the companies in the same industry.
ICL has a better Return On Invested Capital (6.18%) than 62.35% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ICL is significantly above the industry average of 7.11%.
The last Return On Invested Capital (6.18%) for ICL is well below the 3 year average (13.86%), which needs to be investigated, but indicates that ICL had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.6%
ROE 7.11%
ROIC 6.18%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ICL Yearly ROA, ROE, ROICICL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

With a decent Profit Margin value of 5.95%, ICL is doing good in the industry, outperforming 72.94% of the companies in the same industry.
ICL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.33%, ICL is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
ICL's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 32.98%, ICL is doing good in the industry, outperforming 65.88% of the companies in the same industry.
ICL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.33%
PM (TTM) 5.95%
GM 32.98%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
ICL Yearly Profit, Operating, Gross MarginsICL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ICL is still creating some value.
Compared to 1 year ago, ICL has about the same amount of shares outstanding.
ICL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ICL has an improved debt to assets ratio.
ICL Yearly Shares OutstandingICL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ICL Yearly Total Debt VS Total AssetsICL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ICL has an Altman-Z score of 2.64. This is not the best score and indicates that ICL is in the grey zone with still only limited risk for bankruptcy at the moment.
ICL has a Altman-Z score of 2.64. This is in the better half of the industry: ICL outperforms 78.82% of its industry peers.
ICL has a debt to FCF ratio of 3.04. This is a good value and a sign of high solvency as ICL would need 3.04 years to pay back of all of its debts.
ICL has a Debt to FCF ratio of 3.04. This is amongst the best in the industry. ICL outperforms 87.06% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that ICL is not too dependend on debt financing.
The Debt to Equity ratio of ICL (0.33) is better than 70.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 3.04
Altman-Z 2.64
ROIC/WACC0.79
WACC7.82%
ICL Yearly LT Debt VS Equity VS FCFICL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

ICL has a Current Ratio of 1.54. This is a normal value and indicates that ICL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.54, ICL is not doing good in the industry: 62.35% of the companies in the same industry are doing better.
A Quick Ratio of 0.84 indicates that ICL may have some problems paying its short term obligations.
ICL's Quick ratio of 0.84 is on the low side compared to the rest of the industry. ICL is outperformed by 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.84
ICL Yearly Current Assets VS Current LiabilitesICL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The earnings per share for ICL have decreased strongly by -33.33% in the last year.
Looking at the last year, ICL shows a decrease in Revenue. The Revenue has decreased by -8.59% in the last year.
ICL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.35% yearly.
EPS 1Y (TTM)-33.33%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-20%
Revenue 1Y (TTM)-8.59%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%-5.27%

3.2 Future

ICL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.38% yearly.
ICL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.04% yearly.
EPS Next Y15.35%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
EPS Next 5YN/A
Revenue Next Year2.39%
Revenue Next 2Y3.23%
Revenue Next 3Y3.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICL Yearly Revenue VS EstimatesICL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
ICL Yearly EPS VS EstimatesICL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.03, ICL is valued on the expensive side.
ICL's Price/Earnings ratio is in line with the industry average.
ICL is valuated rather cheaply when we compare the Price/Earnings ratio to 23.99, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 15.63, the valuation of ICL can be described as correct.
ICL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.35. ICL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.03
Fwd PE 15.63
ICL Price Earnings VS Forward Price EarningsICL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICL is valued a bit cheaper than the industry average as 68.24% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ICL is valued a bit cheaper than the industry average as 78.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.71
EV/EBITDA 7.7
ICL Per share dataICL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

ICL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ICL may justify a higher PE ratio.
PEG (NY)1.17
PEG (5Y)N/A
EPS Next 2Y15.01%
EPS Next 3Y10.38%

3

5. Dividend

5.1 Amount

ICL has a Yearly Dividend Yield of 2.80%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.84, ICL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, ICL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

The dividend of ICL decreases each year by -1.81%.
ICL has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-1.81%
Div Incr Years0
Div Non Decr Years0
ICL Yearly Dividends per shareICL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

ICL pays out 61.67% of its income as dividend. This is not a sustainable payout ratio.
DP61.67%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
ICL Yearly Income VS Free CF VS DividendICL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B
ICL Dividend Payout.ICL Dividend Payout, showing the Payout Ratio.ICL Dividend Payout.PayoutRetained Earnings

ICL GROUP LTD

NYSE:ICL (5/7/2025, 5:18:32 PM)

After market: 6.82 -0.03 (-0.44%)

6.85

+0.01 (+0.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)05-19 2025-05-19
Inst Owners23.59%
Inst Owner Change-1.44%
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap8.84B
Analysts46.67
Price Target0.05 (-99.27%)
Short Float %0.29%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly Dividend0.19
Dividend Growth(5Y)-1.81%
DP61.67%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-12 2025-03-12 (0.1469338)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.04%
Min EPS beat(2)0.9%
Max EPS beat(2)25.18%
EPS beat(4)4
Avg EPS beat(4)11.74%
Min EPS beat(4)0.9%
Max EPS beat(4)25.18%
EPS beat(8)6
Avg EPS beat(8)11.15%
EPS beat(12)9
Avg EPS beat(12)20.36%
EPS beat(16)13
Avg EPS beat(16)23.32%
Revenue beat(2)0
Avg Revenue beat(2)-2.77%
Min Revenue beat(2)-4.13%
Max Revenue beat(2)-1.41%
Revenue beat(4)0
Avg Revenue beat(4)-3.07%
Min Revenue beat(4)-5.35%
Max Revenue beat(4)-1.41%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.37%
PT rev (3m)12.84%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)-9.17%
EPS NY rev (1m)-2.47%
EPS NY rev (3m)1.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.42%
Revenue NY rev (3m)-1.23%
Valuation
Industry RankSector Rank
PE 18.03
Fwd PE 15.63
P/S 1.29
P/FCF 11.71
P/OCF 6.02
P/B 1.54
P/tB 1.82
EV/EBITDA 7.7
EPS(TTM)0.38
EY5.55%
EPS(NY)0.44
Fwd EY6.4%
FCF(TTM)0.59
FCFY8.54%
OCF(TTM)1.14
OCFY16.61%
SpS5.3
BVpS4.44
TBVpS3.76
PEG (NY)1.17
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.6%
ROE 7.11%
ROCE 8.62%
ROIC 6.18%
ROICexc 6.5%
ROICexgc 7.24%
OM 11.33%
PM (TTM) 5.95%
GM 32.98%
FCFM 11.04%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ROICexc(3y)14.67%
ROICexc(5y)11.45%
ROICexgc(3y)16.24%
ROICexgc(5y)12.7%
ROCE(3y)19.96%
ROCE(5y)15.59%
ROICexcg growth 3Y-15.7%
ROICexcg growth 5Y-1.81%
ROICexc growth 3Y-15.48%
ROICexc growth 5Y-2.08%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 3.04
Debt/EBITDA 1.39
Cap/Depr 119.63%
Cap/Sales 10.42%
Interest Coverage 6.35
Cash Conversion 107.08%
Profit Quality 185.5%
Current Ratio 1.54
Quick Ratio 0.84
Altman-Z 2.64
F-Score4
WACC7.82%
ROIC/WACC0.79
Cap/Depr(3y)138.38%
Cap/Depr(5y)133.57%
Cap/Sales(3y)9.41%
Cap/Sales(5y)9.89%
Profit Quality(3y)123.56%
Profit Quality(5y)409.37%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-20%
EPS Next Y15.35%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.59%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%-5.27%
Revenue Next Year2.39%
Revenue Next 2Y3.23%
Revenue Next 3Y3.04%
Revenue Next 5YN/A
EBIT growth 1Y-32.08%
EBIT growth 3Y-13.49%
EBIT growth 5Y0.95%
EBIT Next Year82.26%
EBIT Next 3Y21.85%
EBIT Next 5YN/A
FCF growth 1Y-7.36%
FCF growth 3Y18.48%
FCF growth 5Y12.66%
OCF growth 1Y-7.96%
OCF growth 3Y11.29%
OCF growth 5Y8.15%